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Introduction 
Leishmaniasis is one of several parasitic diseases which contribute to the high rate 
of mortality in developing countries.  In addition, several hundreds of people are now 
dually infected with HIV and leishmaniasis, making both infections harder to treat.  
Leishmaniasis has also been an epidemic in countries such as Sudan, India and 
Afghanistan.  Current antileishmanial drugs have severe limitations such as toxicity, the 
development of resistance and administration by injection [1].   
 The research currently being done to find better antileishmanial drugs is very 
limited due to the limited number of resources the pharmaceutical industry is willing to 
commit to such work.  The lack of funding available to such research is due to 
economics:  People of developing countries simply will not be able to pay for the drugs 
developed by pharmaceutical companies as a result of research in this area. 
Consequently, research focused on finding new drugs against these parasitic diseases 
becomes the responsibility of academia and other non-profit organizations.   
 The current research in this area focuses on developing drug treatment that is 
more affordable and more easily administered than the current treatment options which 
have many limitations. The goal of the research is to develop drug treatment which will 
target a critical process in the parasites, but will not be toxic to the mammalian host.  
Concurrently, Dr. Werbovetz’s lab has been synthesizing and evaluating the 
effectiveness of dinitroaniline sulfonamides to achieve this goal which are shown in 
Figure 1 [2,3].   
 
 
 
 
Figure 1. Dinitroaniline sulfonamides studied in Dr. Werbovetz’s lab. 
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This project mirrors what has already been done with the dinitroaniline sulfonamides, but 
using a new class of molecules as antiparasitic drug candidates which was identified 
through previous random screening of a compound library.  The lead antileishmanial 
compounds which were identified at Walter Reed are shown in Figure 2.             
    
Figure 2.  Antileishmanial lead compounds identified at Walter Reed.  
 
The first portion of my project focused on the synthesis of 4-chloro-2-(chloromethyl)-
6,7,8,9-tetrahydro-5H-indeno[2,1-d]pyrimidine, (4), to which different functional groups 
can be added to create a series of new molecules with the hope of preparing 
compounds with good antiparasitic activity.  Once 4 had been synthesized, 9 novel 
compounds each with different R groups were synthesized (see Scheme 1).  These 
compounds were then tested for their effectiveness in selectively inhibiting the growth of 
Leishmania parasites and not harming mammalian cells.   
 
Materials & Methods  
Chemistry 
General Methods.  
Unless otherwise indicated, all reagents and solvents were from Aldrich and were 
used without further purification.  The melting points were measured on a Thomas-
Hoover capillary melting point apparatus and are uncorrected.  Nuclear magnetic 
resonance (NMR) spectra were recorded on Bruker 250 and 300 MHz NMR 
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spectrometers.  Thin-layer chromatography was conducted on precoated TLC plates 
from E. Merck.   
 2-Amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile (3).  Compound 3 
was prepared according to the method of Gewald et al. [4]: yield, 31.5%; mp =142 °C; 1H 
NMR (CDCl3) δ 1.76-1.86 (m, 4H), 2.50-2.55 (m, 4H), 4.61 (bs, 2H).  
 4-Chloro-2-(chloromethyl)-6,7,8,9-tetrahydro-5H-indeno[2,1-d]pyrimidine (4). A 
suspension of 3 (4.00 g, 0.0225 mol), chloroacetonitrile (3.39 g, 0.0450 mol) and 
dioxane (22.5 ml, 0.264 mol) was stirred for eight hours in the presence of dry HCl gas 
at 5-10°C.   The solution was then neutralized upon which a solid precipitated out.   The 
crude product 4 was re-crystallized from hexanes and yielded 1.5 g (23%) of 4 as light 
yellow crystals: mp 92 °C; 1H NMR (CDCl3) δ 1.90-1.98 (m, 4H), 2.89-2.92 (m, 2H), 3.10-
3.13 (m, 2H), 4.78 (s, 2H); HRMS (ESI) calcd for C11H10Cl2N2NaS (M + Na)+ 294.9839, 
measured (M + Na)+ 294.9839. 
General Methods for 5a-i.  A suspension of 4 (1 equiv), the desired amine (10 
equiv) and methanol (10 ml) were combined in a round bottom flask and allowed to stir 
at reflux for three hours.   5a-i were purified using column chromatography performed on 
basic alumina gel and the products were eluted using 9:1 hexanes:ethanol.  
N-Ethyl-2-[(ethylamino)methyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-
d]pyrimidin-4-amine (5b).  Yield 11.3 mg (5.7%) 1H NMR (CDCl3) δ 1.19-1.28 (m, 6H), 
1.91 (m, 5H), 2.75-2.90 (m, 6H), 3.60-3.64 (m, 2H), 4.17 (s, 2H), 5.13 (bs, 1H); 13C NMR 
(CDCl3) δ 15.01, 22.62, 25.39, 26.38, 30.90, 35.82, 47.73, 54.94, 60.04, 114.08, 125.07, 
131.97, 157.16, 163.10, 165.96.  
N-Propyl-2-[(propylamino)methyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-
d]pyrimidin-4-amine (5c).  Yield 37 mg (8.4%), 1H NMR (CDCl3) δ 0.84 (t, J = 7.5 Hz, 
3H), 0.99 (t, J = 7.5 Hz, 3H), 1.60-1.70 (m, 4H), 1.88-1.94 (m, 5H), 2.77-2.90 (m, 6H), 
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3.53-3.59 (m, 2H), 4.17 (s, 2H), 5.21 (t, J = 5.4 Hz, 1H); 13C NMR (CDCl3) δ 11.54, 
11.97, 20.91, 22.62, 22.68, 22.86, 25.39, 26.40, 42.62, 55.87, 60.63, 114.07, 125.05, 
131.88, 157.29, 163.25, 165.98; HRMS (ESI) calcd for C17H27N4S (M + H)+ 319.1956, 
measured (M + H)+ 319.1955. 
N-Butyl-2-[(butylamino)methyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-
d]pyrimidin-4-amine (5d). Yield 8 mg (3.4%) 1H NMR (CDCl3) δ 0.87 (t, J = 7.4 Hz, 3H), 
0.97 (t, J = 7.4 Hz, 3H), 1.25-1.68 (m, 8H), 1.88-1.94 (m, 5H), 2.77-2.90 (m, 6H), 3.57-
3.63 (m, 2H), 4.16 (s, 2H), 5.17 (t, J = 5.2 Hz, 1H); 13C NMR (CDCl3) δ 13.90, 14.11, 
20.25, 20.74, 22.62, 22.68, 25.39, 26.38, 29.77, 31.78, 40.61, 53.54, 60.56, 114.07, 
125.04, 131.91, 157.28, 162.61, 165.91. 
2-(Anilinomethyl)-N-phenyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-
amine (5e). Yield 75 mg (28.1%)  1H NMR (CDCl3) δ 1.94-2.03 (m, 4H), 2.86-2.90 (m, 
2H), 3.06-3.10 (m, 2H), 4.48 (s, 2H), 5.12 (bs, 1H), 6.70-6.76 (m, 3H), 7.13-7.25 (m, 4H), 
7.37-7.42 (m, 2H), 7.62-7.65 (m, 2H); 13C NMR (CDCl3) δ 22.44, 22.56, 25.53, 26.43, 
49.39, 113.18, 115.00, 117.26, 121.11, 123.87, 124.69, 128.95, 129.21, 134.06, 138.49, 
148.05, 154.66, 160.86, 166.81.  
 
Biological Evaluation 
Testing against L. donovani axenic amastigotes.  This assay was conducted as 
described previously by Havens et al. [5].  Briefly, L. donovani axenic amastigotes were 
seeded at 106 parasites/mL in 96-well flat-bottom plates with serial dilutions of the 
compound of interest.  Plates were incubated for three days at 37°C, then the CellTiter 
reagent (Promega, Inc.) was added to assess cell viability. The absorbance of each well 
was measured after a four hour incubation to determine the concentration which 
inhibited growth of the parasites by 50% compared with the control. 
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Testing against Vero cells.  The toxicity of the compounds against Vero cells was 
carried out as outlined by Salem and Werbovetz [6].  Briefly, Vero cells were plated at 
104 cells/mL with serial dilutions of compounds for three days at 37°C, then viability was 
assessed using the CellTiter Reagent as described above.  
 
Results & Discussion 
Chemistry 
 Thieno[2,3]-pyrimidines were prepared as outlined in Scheme 1. 
Scheme 1.  Reagents and conditions: (i) diethylamine, ethanol, 40 °C [5,6]; (ii) Dry HCl 
gas, chloroacetonitrile, dioxane 5-10 °C for 8 hours [4,7]; (iii) NHR1R2, methanol, reflux 
 
Cyclohexanone, malononitrile and elemental sulfur were combined the presence of 
ethanol and diethylamine.   This reaction mixture was stirred at 40 °C for 24 hours.  The 
workup was carried out using ethanol to re-crystallize the crude solid that formed during 
the reaction.  This provided 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile 
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(3) in approximately 40% yield.  Compound 3, chloroacetonitrile and dioxane were then 
combined and allowed to stir in the presence of dry HCl gas at 5-10 °C for eight hours.  
The reaction mixture was then basified with sodium bicarbonate.  The solid was then re-
crystallized in hexane resulting in 4, my molecular building block.  Compound 4 was then 
combined with the amines indicated in Scheme 1 in the presence of methanol and 
allowed to stir for four hours.   
A homologation series was formed by synthesizing five compounds with alkylamine 
chain lengths varying from one to six carbons.  A compound with phenyl substituents, a 
compound with a branched alkyl chain, a compound containing tertiary amines and a 
compound with cyclopentyl substituents completed the series as shown in Scheme 1. 
 One of the original aims of the project was to synthesize mono-addition products so 
that compounds bearing two different amine substitutions could be tested on the 
parasites, resulting in a more complete structure activity relationship.  Thin-Layer 
Chromatography was used to determine when a mono-addition product versus the di-
addition product was formed.  Using methanol as the solvent for the reaction between 4 
and the amines, the spots for these two products were so close in Rf that they almost 
appeared as one spot on the TLC plate.  The reaction was run in various solvents to see 
if this would change the reactivity of compound 4 with amines.  The solvents tested 
included dichloromethane, chloroform, ethanol, DMF and pyridine.  In none of these 
solvents did a mono addition product form separately from the di addition product.   The 
amine used as the nucleophile to test the effect of these solvents on the reaction was 
diethylamine since the reaction seemed to run the slowest according to TLC.   
Additionally, the reaction was run at 0 °C using propylamine as the nucleophile; 
however, in this case, no reaction was observed.  Room temperature was the lowest 
temperature at which the reaction between 4 and propylamine would occur at a 
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reasonable rate.  Consequently, running the reaction at 0 °C also did not allow for mono-
addition.   
 The yields of the target compounds were very low with 5a-d all being below 10%.  
One of the reasons for this was the purification process.  The crude yields were often 
greater than 50%, however, much of this material was lost on the alumna column.  The 
yields of compounds 5e-i was more than twice that of 5a-d.   There are two reasons for 
this.  First, as more targets compounds were prepared, the technique improved and 
consequently, the yields did as well.  Second, compounds 5e-i were prepared using 
higher molecular weight amines which were less likely to evaporate during the reaction 
than the lower molecular weight amines used earlier.   
 
Biological Testing 
 Compounds 5a-i have been tested for their effectiveness in inhibiting the growth of L. 
donovani axenic amastigotes and 5a-d have been evaluated for toxicity against African 
Green Monkey kidney (Vero) cells.  These results are shown in Table 1.    
Table 1. Activity of Compounds Against L. donovani and Vero Cells In Vitro 
       
Compound Average IC50 vs L. donovani (µM) IC50 vs Vero Cells (µM) 
Pentamidine 1.7 ± 0.47a  
5a 2.4 ± 0.52a 12 
5b 5.0 ± 0.86a 6.0 
5c 3.8 ± 1.3a 5.3 
5d 3.9 ± 0.52a 6.1 
5e >100 NTc 
5f 16-22b NT 
5g 9.7-21b NT 
5h 28-58b NT 
5i >50 NT 
aResults expressed as the mean ± standard deviation of three independent experiments 
bResults expressed as the range of two independent experiments 
cNot tested 
The best anti-parasitic activity was seen in the compounds containing short alkyl amine 
substitutions.  The hexylamine compound 5f and the isopropyl amine compound 5g 
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showed lower antileishmanial activity, indicating that longer alkyl chains or branched 
chains lead to a loss of activity.  Addition of aromatic groups and cyclic groups 
essentially eliminated all antiparasitic activity.  
 In conclusion, this work illustrates that the short alkyl amine compounds have the 
best antiparasitic activity.  Moreover, the methylamine compound 5a exhibited the best 
selectivity ratio of all the compounds.  Further research to identify the antiparasitic target 
of 5a as well as analogs to promote more specificity and potency may prove to be a 
successful approach in the search for improved antileishmanial therapy.   
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Appendix A.  NMR Spectra for 5b-e.   Mass Spectrometry for 5c. 
 
Figure A1. Proton NMR Spectrum for 5b. 
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Figure A2a. Proton NMR Spectrum for 5c. 
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Figure A2b. Carbon 13 NMR Spectrum for 5c. 
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Figure A2c. Mass Spectrometry for 5c. 
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Figure A3. Proton NMR Spectrum for 5d. 
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Figure A4. Proton NMR Spectrum for 5e. 
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